Home › Hereditary Sensory and Autonomic Neuropathies › Massachusetts › Boston
Hereditary Sensory and Autonomic Neuropathies clinical trials in Boston, MA
6 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of ACR-2316 in Specific Advanced Solid Tumors
RecruitingPhase 1/2
- Beth Israel Deaconess Medical Center, Boston
Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
RecruitingObservational study
- Boston Children's Hospital, Boston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
RecruitingPhase 1
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
The Cancer of the Pancreas Screening-5 CAPS5)Study
RecruitingPhase 3
- Dana Farber Cancer Center, Harvard University, Boston
Hereditary Sensory and Autonomic Neuropathies trials in other cities
- Arlington, VA7 studies
- San Antonio, TX7 studies
- Nashville, TN6 studies
- New York City, NY6 studies
- Houston, TX5 studies
- Philadelphia, PA5 studies
- Portland, OR4 studies
- Ann Arbor, MI4 studies
- Pittsburgh, PA4 studies
- Washington, DC4 studies
- San Francisco, CA3 studies
- Aurora, CO3 studies
Other studies in Boston
- Breast Cancer112 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)85 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.